Platinum OpinionA New Proposal to Risk Stratify Urothelial Carcinomas of the Upper Urinary Tract (UTUCs) in a Predefinitive Treatment Setting: Low-risk Versus High-risk UTUCs
Section snippets
Conflicts of interest
The authors have nothing to disclose.
References (15)
- et al.
European guidelines on upper tract urothelial carcinomas: 2013 update
Eur Urol
(2013) - et al.
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature
Eur Urol
(2012) - et al.
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma
J Urol
(2010) - et al.
Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma
Urology
(2007) - et al.
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma
J Urol
(2004) - et al.
Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy
Urology
(2007) - et al.
The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival
J Urol
(2009)
Cited by (53)
French AFU Cancer Committee Guidelines – Update 2022–2024: Upper urinary tract urothelial cancer (UTUC)
2022, Progres en UrologieCitation Excerpt :Preoperative staging of UUT-UC is difficult. In order not to fail to recognise locally advanced disease or disease with a high risk of progression, a risk group classification is proposed mainly to select the best candidates for conservative treatment [58,59] (level of evidence: 4) (Table 2): Low-risk UUT-UC (all criteria present): low biopsy grade, negative urine cytology for high grade (Paris 2022), non-invasive appearance on imaging, unifocal disease, tumour size < 2 cm, possibility of complete conservative treatment.
Upper urinary tract urothelial cell carcinoma
2022, Immunological Implications and Molecular Diagnostics of Genitourinary CancerConservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
2021, European Urology Open SciencePhase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer
2021, Urologic Oncology: Seminars and Original InvestigationsSurgery for Bladder and Upper Tract Urothelial Cancer
2021, Hematology/Oncology Clinics of North AmericaCitation Excerpt :Although the risk of tumor extravasation and dissemination with URS is low, there are some studies showing that it may be associated with an increase in bladder recurrences, so it should be used only in patients with doubtful diagnosis or when organ-preservation strategies are being considered.141–143 Kidney-sparing approaches can be offered to patients with low-risk UTUC, including tumors with all the following characteristics: unifocal disease, tumor size less than 2 cm, low-grade cytology, low-grade URS biopsy, and noninvasive appearance on imaging.144,145 In these patients, survival is comparable with radical treatment, irrespective of the function of the opposite kidney.146